It should not be combined with other GLP-1based weight-loss agents or medications used to treat insulin-mediated conditions, as this combination may significantly increase the risk of hypoglycemia (dangerously low blood sugar levels)
Adherence in trials is artificially high for instance, 92.8% of patients in a 2-year semaglutide trial completed the study (source)
Your doctor can also help you with a new prescription if necessary to make sure your weight loss journey continues to be safe, effective, and uninterrupted
Abbreviations ACF : Aberrant crypt foci ASD : Autism spectrum disorder BDNF : Brain-derived neurotrophic factor CEA : Carcinoembryonic antigen CIP-SeNPs : Inulin-type fructan CIP70-1 based selenium nanoparticles CMPA : Cows milk protein allergy CRP : C-reactive protein DMH : 1,2-Dimethylhydrazine DP : Degree of polymerization FFAR2 : Free fatty acid receptor 2 FFAR3 : Free fatty acid receptor 3 GIT : Gastrointestinal tract GLP-1 : Glucagon-like peptide-1 GPR43 : G-protein coupled receptor 43 GLUT4 : Glucose transporter type 4 HbA1c : Hemoglobin A1c HDL-C : High-density lipoprotein cholesterol L-cell : Specialized enteroendocrine cell in the gut producing hormones like GLP-1 and PYY LDL-C : Low-density lipoprotein cholesterol PLON-R : Oral Language Task of Navarra-Revised PYY : Peptide YY SCFAs : Short-chain fatty acids TAG : Triacylglycerol TNF- : Tumor necrosis factor-alpha References Gibson GR, Roberfroid MB
Treatment requires medical evaluation and prescription
Berberine Action: Improves insulin sensitivity, regulates blood sugar, supports gut microbiota indirectly stimulates GLP-1 Dosage: 500 mg 2-3 times a day (before meals) Efficacy: Equivalent to metformin (a diabetes medication) in some studies 2
